A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma [3] (multiple letters)

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4507-4510

  Fatemi, Shireen ^a   LoPresti, Jonathan S ^b   Mazzaferri, Ernest L ^c   Robbins, Richard J ^d   Braverman, Lewis E ^d   Pacini, Furio ^d   Haugen, Bryan ^d   Wartofsky, Leonard ^d   Braunstein, Glen D ^d   Ladenson, Paul W ^d   Pinchera, Aldo ^d  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c MACP   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROID HORMONE;

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; FOLLOW UP; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; ULTRASOUND;

BIOLOGICAL MARKERS; CARCINOMA, PAPILLARY; CONSENSUS DEVELOPMENT CONFERENCES; DISEASE PROGRESSION; HUMANS; PROGNOSIS; RISK; THYROGLOBULIN;

EID: 0141452976     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030951     Document Type: Letter

References (0)